SURGICAL INNOVATIONS GROUP PLC

Regulatory Filings • Feb 28, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1518G

Surgical Innovations Group PLC

28 February 2018

Surgical Innovations Group plc

("Surgical Innovations")

Elemental Healthcare extend Microline inc. distribution agreement

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery ("MIS"), announces that its wholly owned subsidiary, Elemental Healthcare Limited, has signed an additional three year exclusive UK distribution agreement with Microline Surgical Inc, Boston USA ("Microline") which was due for renewal on 31 March 2018.  Microline manufactures instruments for MIS that are complementary to the Surgical Innovations branded range.  The new distribution agreement is expected to generate revenue of an estimated £7m over the duration of the contract.

David Marsh, Group Commercial Director of Surgical Innovations Group plc, commented: "Microline has been one of the cornerstones of the Elemental Healthcare business for the last ten years and we are delighted to continue this partnership. Microline share the same ethos of cost containment and reduction in clinical waste as Surgical Innovations, allowing Elemental Healthcare to provide unique solutions to the NHS and private healthcare providers which make significant savings with procedural kits."

Johan van Doremalen, General Manager EMEA, Microline Surgical BV commented: "Elemental Healthcare has been an important partner for us in Europe for nearly 10 years and we are delighted to continue this relationship with one of the leading MIS distributors in the UK."

For further information please contact:

Surgical Innovations Group plc	www.sigroupplc.com
Nigel Rogers, Executive Chairman	Tel: 0113 230 7597
Melanie Ross, COO & CFO
WH Ireland Limited (NOMAD & Broker)	Tel: 0113 394 6600
Tim Feather Alex Bond
Walbrook PR  (Financial PR & Investor Relations)	Tel: 020 7933 8780 or si@walbrookpr.com
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

AGRGMGZZRNMGRZM